Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

Mizuho initiated coverage of Embecta (EMBC) with a Neutral rating and $15 price target The firm says its rating balances the company’s ...

Assad, unleashed a Sarin gas strike on the suburbs of Damascus in 2013, killing at least 1,500. Now, the survivors want ...

The global injectable drug delivery devices market size was estimated at USD 519 billion in 2024 and is predicted to reach ...

Needles in pens are often smaller than those in syringes. Not all types of insulin can be used with a pen. Pens can be more expensive than syringes and are sometimes not covered by insurance.

This market research report provides an in-depth analysis of the Injectable Drug Delivery Market, projecting significant ...

Among these are needle device-based treatments that have ... and Auvi-Q® marketed by Kaleo Inc. and syringe device Symjepi® marketed by US Worldmeds. In August 2024, ARS Pharmaceuticals, Inc ...

The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as the first needle-free treatment ... pre-filled syringe and pen injector formulations of glucagon ...

Find Needle Syringe stock video, 4K footage, and other HD footage from iStock. Get higher quality Needle Syringe content, for less—All of our 4K video clips are the same price as HD. Video Back Videos ...

Ebgylss comes in two dosage forms: a prefilled syringe and a prefilled pen, both with a needle shield. If your health care provider decides that you or a caregiver can inject Ebglyss at home ...